Cardiovascular Protective Effects of Adjunctive Alternative Medicine (Salvia miltiorrhiza and Pueraria lobata) in High-Risk Hypertension

Table 4

Percent change of FMD from baseline.

Group	Baseline (mm)	6 months (%)	12 months (%)	𝑃 value^1	𝑃 value^2
D&G (1 gm)	5.38±1.89	21.6	27.8	0.001	0.001
D&G (2 gm)	4.97±1.52	24.7	32.2	0.001	0.001
D&G (2 gm + 1 gm)	5.17±1.71	23.2	30.2	0.001	0.001
Placebo	5.46±1.27	10.0	15.5	0.001	0.001
𝑃 value^3	0.867	0.147	0.171
𝑃 value^4	0.275	0.063	0.05
𝑃 value^5	0.465	0.031	0.028

𝑃 value¹: comparison of 6 months versus baseline.
𝑃 value²: comparison of 12 months versus baseline.
𝑃 value³: comparison between D&G (1 gm) with placebo (Kruskal-Wallis test).
𝑃 value⁴: comparison between D&G (2 gm) with placebo (Kruskal-Wallis test).
𝑃 value⁵: comparison between D&G (2 gm + 1 gm) with placebo (Mann-Whitney test).